MORPHOSYS AG O.N. - 1H - Technical analysis published on 02/06/2024 (GMT)
- 164
- 0
Click here for a new analysis!
- Timeframe : 1H
- - Analysis generated on
- Status : LEVEL MAINTAINED
Summary of the analysis
Additional analysis
Quotes
MORPHOSYS AG O.N. rating 65.52 EUR. The price has increased by +14.15% since the last closing and was between 65.26 EUR and 66.58 EUR. This implies that the price is at +0.40% from its lowest and at -1.59% from its highest.A bullish gap was detected at the opening by the Central Gaps scanner. There are a lot of buyers and they have the upper hand in the very short term.
Opening Gap UP
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
New HIGH record (1 year)
Type : Bullish
Timeframe : Weekly
New HIGH record (1st january)
Type : Bullish
Timeframe : Weekly
New HIGH record (1 month)
Type : Bullish
Timeframe : Weekly
The Central Volumes scanner detects abnormal volumes on the asset:
Abnormal volumes
Timeframe : 5 days
Abnormal volumes
Timeframe : 20 days
Abnormal volumes
Timeframe : 50 days
Technical
Technical analysis of MORPHOSYS AG O.N. in 1H shows a strongly overall bullish trend. 92.86% of the signals given by moving averages are bullish. The overall trend is supported by the strong bullish signals from short-term moving averages. The Central Indicators scanner does not detect any result on moving averages that would impact this trend.
An assessment of technical indicators shows a strong bullish signal.
Caution: the Central Indicators scanner currently detects an excess:
RSI indicator is overbought : over 80
Type : Neutral
Timeframe : 1 hour
CCI indicator is overbought : over 100
Type : Neutral
Timeframe : 1 hour
Previous candle closed over Bollinger bands
Type : Neutral
Timeframe : 1 hour
Williams %R indicator is overbought : over -20
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 1
Type : Neutral
Timeframe : 1 hour
Pivot points : price is over resistance 3
Type : Neutral
Timeframe : Weekly
No signals are given by Central Patterns, a market scanner specialised in chart patterns, resistances and supports.
The Central Candlesticks scanner which studies Japanese candlesticks did not detect anything.
S3 | S2 | S1 | Price | R1 | R2 | R3 | |
---|---|---|---|---|---|---|---|
ProTrendLines | 40.95 | 44.44 | 54.96 | 65.52 | 70.20 | 86.72 | 101.02 |
Change (%) | -37.50% | -32.17% | -16.12% | - | +7.14% | +32.36% | +54.18% |
Change | -24.57 | -21.08 | -10.56 | - | +4.68 | +21.20 | +35.50 |
Level | Intermediate | Intermediate | Intermediate | - | Minor | Major | Intermediate |
To determine price objectives, it is also possible to use the pivot points. Here is the price position in relation to pivot points:
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 26.82 | 33.37 | 45.39 | 51.94 | 63.96 | 70.51 | 82.53 |
Camarilla | 52.29 | 54.00 | 55.70 | 57.40 | 59.10 | 60.81 | 62.51 |
Woodie | 29.55 | 34.74 | 48.12 | 53.31 | 66.69 | 71.88 | 85.26 |
Fibonacci | 33.37 | 40.47 | 44.85 | 51.94 | 59.04 | 63.42 | 70.51 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 32.80 | 35.59 | 38.87 | 41.66 | 44.94 | 47.73 | 51.01 |
Camarilla | 40.49 | 41.05 | 41.60 | 42.16 | 42.72 | 43.27 | 43.83 |
Woodie | 33.06 | 35.71 | 39.13 | 41.78 | 45.20 | 47.85 | 51.27 |
Fibonacci | 35.59 | 37.91 | 39.34 | 41.66 | 43.98 | 45.41 | 47.73 |
Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
---|---|---|---|---|---|---|---|
Standard | 19.54 | 24.63 | 32.02 | 37.11 | 44.50 | 49.59 | 56.98 |
Camarilla | 35.97 | 37.11 | 38.26 | 39.40 | 40.54 | 41.69 | 42.83 |
Woodie | 20.68 | 25.21 | 33.16 | 37.69 | 45.64 | 50.17 | 58.12 |
Fibonacci | 24.63 | 29.40 | 32.35 | 37.11 | 41.88 | 44.83 | 49.59 |
Numerical data
The following is the status of the technical indicators and moving averages at the time of publication of this technical analysis:
RSI (14): | 89.19 | |
MACD (12,26,9): | 5.6100 | |
Directional Movement: | 59.71 | |
AROON (14): | 50.00 | |
DEMA (21): | 56.05 | |
Parabolic SAR (0,02-0,02-0,2): | 42.70 | |
Elder Ray (13): | 12.37 | |
Super Trend (3,10): | 57.51 | |
Zig ZAG (10): | 65.54 | |
VORTEX (21): | 1.3300 | |
Stochastique (14,3,5): | 96.22 | |
TEMA (21): | 60.30 | |
Williams %R (14): | -4.13 | |
Chande Momentum Oscillator (20): | 23.34 | |
Repulse (5,40,3): | 6.6200 | |
ROCnROLL: | 1 | |
TRIX (15,9): | 0.9300 | |
Courbe Coppock: | 66.82 |
MA7: | 46.33 | |
MA20: | 39.17 | |
MA50: | 33.58 | |
MA100: | 29.97 | |
MAexp7: | 58.36 | |
MAexp20: | 49.92 | |
MAexp50: | 44.47 | |
MAexp100: | 41.15 | |
Price / MA7: | +41.42% | |
Price / MA20: | +67.27% | |
Price / MA50: | +95.12% | |
Price / MA100: | +118.62% | |
Price / MAexp7: | +12.27% | |
Price / MAexp20: | +31.25% | |
Price / MAexp50: | +47.34% | |
Price / MAexp100: | +59.22% |
News
Don't forget to follow the news on MORPHOSYS AG O.N.. At the time of publication of this analysis, the latest news was as follows:
- EQS-News: MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value
- EQS-Adhoc: Ad hoc: MorphoSys AG Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value and into Purchase Agreement with Incyte for the Sale of Tafasitamab
- EQS-News: MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability
- EQS-Adhoc: Ad hoc: MorphoSys AG Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability
- EQS-News: MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Add a comment
Comments
0 comments on the analysis MORPHOSYS AG O.N. - 1H